Digene to Present at 25th Annual JPMorgan Healthcare Conference
03 Enero 2007 - 6:00AM
PR Newswire (US)
GAITHERSBURG, Md., Jan. 3 /PRNewswire-FirstCall/ -- Digene
Corporation (NASDAQ:DIGE) today announced that Daryl Faulkner,
President and Chief Executive Officer, and Joseph Slattery, Chief
Financial Officer, will be presenting at the 25th Annual JPMorgan
Healthcare Conference on Tuesday, January 9, 2007 at 9:30 a.m.
(PST). This conference will be held at The Westin St. Francis
Hotel, San Francisco, CA. A link to JPMorgan's live webcast and
recording of Digene's presentation will be available on the
Company's website, http://www.digene.com/. The recording of
Digene's presentation will be available beginning on the evening of
January 9, 2007 until approximately April 9, 2007. About Digene A
leader in molecular diagnostics, Digene develops, manufactures and
markets proprietary DNA and RNA tests, with a focus on women's
health. The company's flagship product, the Digene(R) HPV Test, is
the only FDA-approved and CE-marked test for the human
papillomavirus, the cause of essentially all cervical cancers.
Digene's product portfolio also includes tests for the detection of
other sexually transmitted infections, including chlamydia and
gonorrhea. Digene tests are marketed in more than 40 countries
worldwide. Headquartered in Gaithersburg, MD, Digene is traded on
NASDAQ under the symbol DIGE. For more information, visit
http://www.digene.com/ and http://www.thehpvtest.com/. DATASOURCE:
Digene Corporation CONTACT: Albert Fleury, Investor Relations,
Digene Corporation, +1-301-944-7000; or Media: Pam Rasmussen,
Digene, +1-301-944-7196, or Sean Leous, Financial Dynamics,
+1-212-850-5600 Web site: http://www.digene.com/
Copyright
Digene (NASDAQ:DIGE)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Digene (NASDAQ:DIGE)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Digene Corp (MM) (NASDAQ): 0 recent articles
Más de Digene (MM) Artículos de Noticias